# Ritter Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ritter-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: Los Angeles, US
- Website: www.ritterpharmaceuticals.com
- Total disclosed funding: $12M
- Latest round: Series C (Dec 9, 2014)
- Investors on record: 1

## About

Founded in 2004 and based in California, US, Ritter Pharmaceuticals, Inc. operates as a manufacturer of therapeutic products that treat gastrointestinal diseases. The company has developed RP-G28 which is a FDA-approved treatment for lactose intolerance. The company also researches and develops treatments for other gastrointestinal diseases, immuno-oncology, metabolic, and liver disease.

## Funding rounds

- Series C, Dec 9, 2014, $3.7M — Javelin Venture Partners
- Series B, Nov 21, 2013, $1.5M — Javelin Venture Partners
- Series B, Aug 2, 2012, $3.9M — Javelin Venture Partners
- Series B, Nov 25, 2010, $1.9M — Javelin Venture Partners
- Seed, Aug 19, 2009, $1M — Javelin Venture Partners

## Investors

- Javelin Venture Partners (https://capitalatlas.ai/funds/javelin-venture-partners) — Seed, Series B, Series C